Summary
A study was made of 26 patients diagnosed as phase I reflex sympathetic dystrophy. In all of them, a bone: soft tissue uptake index was quantified by scintigraphic scanning before treatment and 3 months later. Eighteen patients were treated with 100 MRC units salmon calcitonin, followed by 500 mg elemental calcium 4 hours after hormone administration. The treatment was administered 10 days a month separated by intervals free of therapy. The other 8 patients were treated without interruption with 500 mg naproxen every 12 hours. In the group treated with calcitonin and calcium, the uptake index declined from 13.3±8.2 to 4.1±1.8 (p<0.001). The uptake index rose from 21.3±17.7 to 31.1±23.0 (NS) in the naproxen group. Using the Student t-test for paired samples to evaluate individual changes, a highly significant difference was reached (p<0.005) in the calcitonin-calcium group. The difference was also significant (p<0.01) in the naproxen group, but it was negative (t=−3.620). These results confirm the efficacy of treating reflex sympathetic dystrophy with calcitonin and calcium and the superiority of this treatment as compared with nonsteroidal anti-inflammatory drugs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sudeck, P. Uber die akute entzundliche Knochenatrophie. Arch Klin Chir 1900, 62, 147–156.
De Seze, S., Reiner, J.C., Caro, H. Les aldodystrophies du genou. Rev Rhum 1960, 27, 9–14.
Kozin, F., McCarthy, D.J., Sims, J., Genant, H. The reflex sympathetic syndrome. Am J Med 1976, 60, 321–331.
Hunter, J. Ouvres completes. Tortin-Masson, Paris, 1864.
Mitchell, S.W., Morehouse G.R., Keen, W.W. Gunshot Wounds and Other Injuries of Nerves. Lippincott. Philadelphia, 1864.
Eisinger, J., Acquaviva, P.C., D'Omezon, Y., Recordier, A.M., Traitment des algodystrophies par la calcitonine: results preliminaires. Marseille Med 1973, 110, 373–376.
Doury, P., Granier, R., Pattin, S. La place de la scintigraphie osseuse aux pyrophosphates de technetium 99m dans le diagnostic des algodystrophies. A propos de 74 observations. Ann Med Intern (Paris) 1979, 130, 553–557.
Takats, G. de Reflex dystrophy of the extremities. Arch Surg 1937, 34, 939–956.
Doury, P., Dirheimer, Y., Pattin, S. Algodystrophy, Diagnosis and Therapy of a Frequent Disease of the Locomotor Apparatus. Springer-Verlag. Berlin. 1981.
Gennat, H.K., Kozin, F., Bekerman, C., McCarthy, D.J., Sims, J. The reflex sympathetic dystrophy syndrome. Radiology 1975, 117, 21–32.
Gennari, C., Francini, G., Gonneli, S., Nami, R. Dolore osseo, endorfine e calcitonine. In: Gennari C, Segre G (eds). The Effects of Calcitonin in Man. Masson, Italia, Milano, 1983, 213–222.
Gaucher, A., Bertrand, A., Wiederkehr, P., Hocquard, C., Raul, P., Adolphe, J. Scintigraphic study of reflex sympathetic dystrophy and osteonecrosis in the adult. In: Arlet, J., Ficat, R.P., Vungerford, D.S. (eds). Bone Circulation, Williams and Wilkins, Baltimore, London, 1984, 76–87.
Renier, J.C., Moreau, R., Bernat, M., Basle, M., Jallet, P., Minier, J.F. Apport des explorations isotopiques dynamiques dans l'étude des algodystrophies. Rev Rhum 1979, 46, 235–241.
Friedman, J., Raisz, L.G. Thyrocalcitonin inhibition of bone resorption in tissue culture. Science 1965, 150, 1465–1567.
Rosenthall, L., Kaye, M. Technetium-99m-pyrophosphate kinetics and imaging in the metabolic bone disease J Nucl Med 1975, 16, 33–39.
Fogelman, I., Bessent, R.G., Turner, J.G., Citrin, D.L., Boyle, I.T., Greig, W.R. The use of whole-body retention of Tc-99m-diphosphonate in the diagnosis of metabolic bone disease. J Nucl Med 1978, 19, 270–275
Greenberg, E.J., Weber, D.A., Pochaczevsky, R., Kenny, P.J., Myers, W.P.L., Laughlin, J.S., Detection of neoplastic bone lesions by quantitative scanning and radiography. J Nucl Med 1968, 9, 613–620.
Wahner, H.W. Assessment of metabolic bone disease: review of new nuclear medicine procedures. Mayo Clin Proc 1985, 60, 827–835.
Subramanian, G., McAfee, J.G. A new complex 99mTc for skeletal imaging. Radiology 1971, 99, 192–196.
Delcambre, B., Duquesnoy, B., Cocheteux, P., Thevenon, A., Delfosse, J.M., Pouyol, F. Traitment des algodystrophies. Rev Rhum 1982, 49, 849–856.
Cushing, H. The basophil adenomas of the pituitary body and their clinical manifestation (Pituitary Basophilism). J Hopkins Med J, 932, 50, 137–195.
Friez, L., Pere, G., Breuillard, Ph., Meignan, S. Comparison du traitement par la griseofulvine, les betabloquants et la calcitonine dans 55 cas d'algoneurodystrophie post-traumatique. Rev Rhum 1982, 49, 857–860.
Driessens, M.F., Vanhoutte, P.M., Mortier, G. Effect of calcitonin, hydrocortisone, and parathyroid hormone on canine bone blood vessels. In: Arlet, J. Ficat, R.P., Mungerford, D.S. (eds). Bone Circulation. Williams and Wilkins, Baltimore, London, 1984, 228–232.
Rico, H. The use of calcitonin as antiosteolitic drug (Editorial). Calcif Tissue Int 1985, 37, 105–106.
Kozin, F., Soin, J.S., Ryan, L.M., Carrera, G.F., Wortmann, R.L. Bone scintigraphy in the reflex sympathetic dystrophy, Radiology 1981, 138, 437–443.
Plewes, L.W. Sudeck's atrophy in the hand. J Bone Joint Surg 1956, 38B, 195–203.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rico, H., Merono, E., Gomez-Castresana, F. et al. Scintigraphic evaluation of reflex sympathetic dystrophy: comparative study of the course of the disease under two therapeutic regimens. Clin Rheumatol 6, 233–237 (1987). https://doi.org/10.1007/BF02201029
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02201029